Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia.
Conclusions: Our results suggest reasonable uptake of risk-reducing interventions in high-risk women. To minimize the occurrence of breast and ovarian cancer in women with a BRCA1 or BRCA2 mutation, more attention could be paid to ensuring that affected women receive proper counselling and follow-up.
PMID: 30853805 [PubMed - in process]
Source: Current Oncology - Category: Cancer & Oncology Tags: Curr Oncol Source Type: research
More News: Breast Cancer | Canada Health | Cancer | Cancer & Oncology | Evista | Fallopian Tube Cancer | Mastectomy | Oral Cancer | Ovarian Cancer | Ovaries | Study | Tamoxifen | UK Health | Women